Efzofitimod 3 mg/kg

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
84	サルコイドーシス	1

84. サルコイドーシス

臨床試験数 : 149 / 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05415137 (ClinicalTrials.gov)	September 15, 2022	8/6/2022	Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ...	Pulmonary Sarcoidosis	Drug: Efzofitimod 3 mg/kg;Drug: Efzofitimod 5 mg/kg;Drug: Placebo	aTyr Pharma, Inc.	Kyorin Pharmaceutical Co.,Ltd	Recruiting	18 Years	75 Years	All	264	Phase 3	United States;Japan;Netherlands;Puerto Rico;Spain

First Previous1Next Last